What is she best known for?
The fields of study she is best known for:
- Cancer
- Internal medicine
- Surgery
Her main research concerns Surgery, Radiation therapy, Internal medicine, Randomized controlled trial and Hazard ratio.
Her biological study spans a wide range of topics, including Cancer and Clinical trial.
Laurence Collette interconnects Salvage therapy, Colorectal cancer, Lung cancer and Breast cancer in the investigation of issues within Radiation therapy.
Her Internal medicine study frequently draws parallels with other fields, such as Oncology.
Her Randomized controlled trial research is multidisciplinary, incorporating perspectives in Stage, Prostatectomy, Prostate cancer and Intensive care medicine.
In her work, Proportional hazards model is strongly intertwined with Survival analysis, which is a subfield of Hazard ratio.
Her most cited work include:
- Chemotherapy with preoperative radiotherapy in rectal cancer (1951 citations)
- Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. (1517 citations)
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial (1453 citations)
What are the main themes of her work throughout her whole career to date?
Her scientific interests lie mostly in Internal medicine, Oncology, Surgery, Prostate cancer and Radiation therapy.
Her work on Cancer, Clinical trial and Hazard ratio as part of general Internal medicine research is frequently linked to In patient, bridging the gap between disciplines.
Her Oncology study incorporates themes from Proportional hazards model, Locally advanced, Disease and Surrogate endpoint.
Her Surgery study combines topics from a wide range of disciplines, such as Colorectal cancer and Breast cancer.
The study incorporates disciplines such as Prostate and Urology in addition to Prostate cancer.
Her Radiation therapy study combines topics in areas such as Regimen, Clinical endpoint and Carcinoma.
She most often published in these fields:
- Internal medicine (50.80%)
- Oncology (40.26%)
- Surgery (39.30%)
What were the highlights of her more recent work (between 2015-2021)?
- Internal medicine (50.80%)
- Oncology (40.26%)
- Randomized controlled trial (17.89%)
In recent papers she was focusing on the following fields of study:
Her primary areas of study are Internal medicine, Oncology, Randomized controlled trial, Clinical trial and Cancer.
Laurence Collette has researched Oncology in several fields, including Prostate cancer, Germ cell cancer and Disease.
Randomized controlled trial is a subfield of Surgery that she explores.
Laurence Collette is studying Radiosurgery, which is a component of Surgery.
Her Cancer research incorporates themes from Crizotinib, MEDLINE and Family medicine.
Her Radiation therapy research is multidisciplinary, incorporating elements of Clinical endpoint, Breast cancer and Confidence interval.
Between 2015 and 2021, her most popular works were:
- EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin (231 citations)
- Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer (168 citations)
- Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial. (123 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
Her primary areas of investigation include Randomized controlled trial, Internal medicine, Oncology, Clinical trial and Cancer.
Randomized controlled trial is a primary field of her research addressed under Surgery.
Her study in the field of Survival rate also crosses realms of BCG vaccine.
Her research integrates issues of Prostate cancer and Disease in her study of Oncology.
Her research in Cancer intersects with topics in Malignancy, Radiation therapy and Quality of life.
The Radiation therapy study combines topics in areas such as Clinical endpoint, Breast cancer and Cumulative incidence.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
